These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9881650)

  • 21. An evaluation method for nonlinear local disposition in rat liver and kidney.
    Kato T; Yamaoka K; Takakura Y
    Drug Metab Dispos; 2004 Feb; 32(2):230-4. PubMed ID: 14744945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic saturation mechanism of ethanol: application of mathematical models to ethanol outflow profiles in the perfused rat liver.
    Matsumoto H; Fukui Y
    Alcohol Clin Exp Res; 1996 Feb; 20(1 Suppl):7A-11A. PubMed ID: 8659696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Application of multi-lines fitting technic for ethenzamide elimination with capacity-limited process in the rabbit plasma].
    Asada S; Fujii H; Nakae H
    Yakugaku Zasshi; 1989 Jul; 109(7):499-504. PubMed ID: 2585261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute dose-dependent disposition studies of nicotinic acid in rats.
    Iwaki M; Ogiso T; Hayashi H; Tanino T; Benet LZ
    Drug Metab Dispos; 1996 Jul; 24(7):773-9. PubMed ID: 8818575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of nonlinear hepatic clearance of a cyclopentapeptide, BQ-123, with the multiple indicator dilution method using the dispersion model.
    Hisaka A; Nakamura T; Sugiyama Y
    Pharm Res; 1999 Jan; 16(1):103-9. PubMed ID: 9950287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Fluoro-2'-deoxyuridine elimination by the isolated perfused rat liver.
    Csaky KG; LaCreta FP; Warren BS; Williams WM
    Cancer Res; 1988 Jul; 48(13):3561-5. PubMed ID: 2967734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of effect of interferon alpha 2a upon fluorouracil pharmacokinetics.
    Seymour MT; Patel N; Johnston A; Joel SP; Slevin ML
    Br J Cancer; 1994 Oct; 70(4):724-8. PubMed ID: 7917928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation.
    Chen TL; Passos-Coelho JL; Noe DA; Kennedy MJ; Black KC; Colvin OM; Grochow LB
    Cancer Res; 1995 Feb; 55(4):810-6. PubMed ID: 7850794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacokinetics of ethanol.
    Holford NH
    Clin Pharmacokinet; 1987 Nov; 13(5):273-92. PubMed ID: 3319346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population pharmacokinetics of hydroxyurea in cancer patients.
    Tracewell WG; Trump DL; Vaughan WP; Smith DC; Gwilt PR
    Cancer Chemother Pharmacol; 1995; 35(5):417-22. PubMed ID: 7850924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation for effect of hypothermia on the disposition of 4-nitrophenol in rats by in-vitro metabolism study and rat liver perfusion system.
    Miyamoto H; Matsueda S; Komori K; Fumoto S; Nakashima M; Yoshikawa N; Hirata H; Shimokawa K; Ohwaki Y; Nishida K
    J Pharm Pharmacol; 2013 Oct; 65(10):1536-40. PubMed ID: 24028621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An application of nonlinear mixed-effects modeling to pharmacokinetic data exhibiting nonlinear and time-dependent behavior.
    Iavarone L; Gomeni R
    J Pharm Sci; 2003 Jan; 92(1):27-34. PubMed ID: 12486679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of age on the disposition and tissue clearances of fluorinated pyrimidines in rats.
    Au JL
    Pharm Res; 1985 Nov; 2(6):279-84. PubMed ID: 24271124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depression of phenytoin metabolic capacity by 5-fluorouracil and doxifluridine in rats.
    Konishi H; Yoshimoto T; Morita K; Minouchi T; Sato T; Yamaji A
    J Pharm Pharmacol; 2003 Jan; 55(1):143-9. PubMed ID: 12625878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A compartmental model of hepatic disposition kinetics: 1. Model development and application to linear kinetics.
    Anissimov YG; Roberts MS
    J Pharmacokinet Pharmacodyn; 2002 Apr; 29(2):131-56. PubMed ID: 12361240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposition and availability of 5-fluorouracil prodrug 5'-deoxy-5-fluorouridine after oral administration in rats.
    Au JL
    J Pharm Sci; 1987 Sep; 76(9):699-702. PubMed ID: 11002805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic evaluation of nonlinear drug elimination by a disposition decomposition analysis. Application to the analysis of the nonlinear elimination kinetics of erythropoietin in adult humans.
    Veng-Pedersen P; Widness JA; Pereira LM; Peters C; Schmidt RL; Lowe LS
    J Pharm Sci; 1995 Jun; 84(6):760-7. PubMed ID: 7562419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.
    Gordi T; Frohna P; Sun HL; Wolff A; Belardinelli L; Lieu H
    Clin Pharmacokinet; 2006; 45(12):1201-12. PubMed ID: 17112296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of steroidal muscle relaxants in isolated perfused rat liver.
    Mol WE; Rombout F; Paanakker JE; Oosting R; Scaf AH; Meijer DK
    Biochem Pharmacol; 1992 Oct; 44(7):1453-9. PubMed ID: 1358074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A population analysis of the pharmacokinetics of Cremophor EL using nonlinear mixed-effect modelling.
    van den Bongard HJ; Mathôt RA; van Tellingen O; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2002 Jul; 50(1):16-24. PubMed ID: 12111107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.